GENEVA, Aug. 21 -- SHANDONG BOAN BIOTECHNOLOGY CO., LTD. filed a patent application (CN2026/078110) for “BISPECIFIC ANTIBODY TARGETING EGFR AND B7H3, AND ANTIBODY-DRUG CONJUGATE THEREOF”. With publication no. WO/2026/171129, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/46
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....